$2.60
0.03[1.17%]
At close: Apr 24
$2.60
0[0.00%]
After Hours: 8:44AM EDT
Cellectis
(NASDAQ:CLLS)Cellectis Stock (NASDAQ:CLLS), Analyst Ratings, Price Targets, Predictions
Cellectis SA has a consensus price target of $7.25, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, Oppenheimer, and JMP Securities on November 1, 2023, August 8, 2023, and August 7, 2023. With an average price target of $7.67 between JMP Securities, Oppenheimer, and JMP Securities, there's an implied 194.87% upside for Cellectis SA from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Oppenheimer
Citigroup
Goldman Sachs
Baird
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cellectis
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/01/2023 | CLLS | Buy Now | Cellectis | $2.60 | 130.77% | JMP Securities | Silvan Tuerkcan | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/08/2023 | CLLS | Buy Now | Cellectis | $2.60 | 323.08% | Oppenheimer | Hartaj Singh | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | CLLS | Buy Now | Cellectis | $2.60 | 130.77% | JMP Securities | Silvan Tuerkcan | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/05/2023 | CLLS | Buy Now | Cellectis | $2.60 | 515.38% | Citigroup | Yigal Nochomovitz | $24 → $16 | Maintains | Buy | Get Alert |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $2.60 | 400% | Oppenheimer | Hartaj Singh | $16 → $13 | Maintains | Outperform | Get Alert |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $2.60 | 130.77% | JMP Securities | Silvan Tuerkcan | → $6 | Reiterates | → Market Outperform | Get Alert |
| 01/19/2023 | CLLS | Buy Now | Cellectis | $2.60 | 130.77% | JMP Securities | Silvan Tuerkcan | $11 → $6 | Maintains | Market Outperform | Get Alert |
| 05/24/2022 | CLLS | Buy Now | Cellectis | $2.60 | -23.08% | Goldman Sachs | Salveen Richter | $3 → $2 | Maintains | Sell | Get Alert |
| 05/18/2022 | CLLS | Buy Now | Cellectis | $2.60 | — | Baird | Jack Allen | — | Upgrade | Neutral → Outperform | Get Alert |
| 05/13/2022 | CLLS | Buy Now | Cellectis | $2.60 | 169.23% | Barclays | Gena Wang | $9 → $7 | Maintains | Overweight | Get Alert |
| 01/06/2022 | CLLS | Buy Now | Cellectis | $2.60 | 515.38% | Wells Fargo | Nick Abbott | → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2021 | CLLS | Buy Now | Cellectis | $2.60 | 669.23% | JMP Securities | Silvan Tuerkcan | — | Initiates | → Market Outperform | Get Alert |
| 10/08/2021 | CLLS | Buy Now | Cellectis | $2.60 | 284.62% | Baird | Jack Allen | — | Downgrade | Outperform → Neutral | Get Alert |
| 04/28/2021 | CLLS | Buy Now | Cellectis | $2.60 | — | Guggenheim | Michael Schmidt | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Cellectis (CLLS)?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on November 1, 2023. The analyst firm set a price target for $6.00 expecting CLLS to rise to within 12 months (a possible 130.77% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellectis (CLLS)?
The latest analyst rating for Cellectis (NASDAQ: CLLS) was provided by JMP Securities, and Cellectis reiterated their market outperform rating.
When was the last upgrade for Cellectis (CLLS)?
The last upgrade for Cellectis SA happened on May 18, 2022 when Baird raised their price target to N/A. Baird previously had a neutral for Cellectis SA.
When was the last downgrade for Cellectis (CLLS)?
The last downgrade for Cellectis SA happened on January 6, 2022 when Wells Fargo changed their price target from N/A to $16 for Cellectis SA.
When is the next analyst rating going to be posted or updated for Cellectis (CLLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellectis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellectis was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.
Is the Analyst Rating Cellectis (CLLS) correct?
While ratings are subjective and will change, the latest Cellectis (CLLS) rating was a reiterated with a price target of $6.00 to $6.00. The current price Cellectis (CLLS) is trading at is $2.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.